Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Dermatol Sci ; 54(2): 99-105, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19264456

RESUMEN

BACKGROUND: Psoriasis is a chronic immune-mediated skin disease, in which interleukins 12 and 23 have been postulated to play a critical role. However, the cellular source of these cytokines in psoriatic lesions are still poorly defined and their relative contribution in inducing skin inflammation has been discussed controversially. OBJECTIVES: To investigate immunoreactivity of the bioactive forms of IL-12 and IL-23 in plaque psoriasis and to characterize the dendritic cell (DC) and macrophage subsets responsible for the production of these cytokines. METHODS: Immunohistochemistry was performed on normal skin (n=11) as well as non-lesional (n=11) and lesional (n=11) skin of patients with plaque psoriasis using monoclonal antibodies targeting the bioactive forms of IL-12 (IL-12p70) and IL-23 (IL-23p19/p40) on serial cryostat sections using the alkaline phosphatase-antialkaline phosphatase. Co-localization of IL-12 and IL-23 with different dendritic cells and macrophage cell markers (CD1a, CD11c, CD14, CD32, CD68, CD163, CD208/DC-LAMP) was performed using double immunofluorescence staining. RESULTS: Immunoreactivity for IL-12 and IL-23 was significantly enhanced in lesional psoriatic skin as compared to non-lesional and normal skin. No difference was observed between IL-12 and IL-23 immunoreactivity in any skin types. Both IL-12 and IL-23 immunoreactivity was readily detected mainly in CD11c+, CD14+, CD32+, CD68+ and some CD163+, DC-LAMP+ cells. IL-12 and occasionally IL-23 were also found in some CD1a+ dendritic cells. In addition, an enhanced expression mainly of IL-23 was observed in keratinocytes. CONCLUSIONS: Bioactive forms of IL-12 and IL-23 are highly expressed in various DC and macrophage subsets and their marked in situ production suggest that both cytokines have crucial pathogenic role in psoriasis.


Asunto(s)
Células Dendríticas/inmunología , Interleucina-12/biosíntesis , Subunidad p19 de la Interleucina-23/biosíntesis , Macrófagos/inmunología , Psoriasis/inmunología , Piel/inmunología , Adulto , Anciano , Anciano de 80 o más Años , Células Dendríticas/citología , Femenino , Humanos , Queratinocitos/inmunología , Macrófagos/citología , Masculino , Persona de Mediana Edad , Psoriasis/patología , Piel/patología
2.
J Dtsch Dermatol Ges ; 4(2): 141-2, 2006 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-16503942

RESUMEN

Treatment of pyogenic granuloma may be difficult in locations such as the face and fingertips. We successfully treated a 1 cm periungual fingertip pyogenic granuloma with a dye laser.


Asunto(s)
Dedos , Granuloma Piogénico/radioterapia , Terapia por Luz de Baja Intensidad , Enfermedades de la Uña/radioterapia , Adulto , Estudios de Seguimiento , Humanos , Masculino
3.
Eur J Dermatol ; 16(1): 79-83, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16436349

RESUMEN

Mycobacterium marinum can cause fish tank granuloma (or swimming pool or aquarium granuloma) in immunocompetent patients. Dissemination of Mycobacterium marinum-infection is a rare condition which occurs mainly in immunocompromised patients and can be life-threatening. We report the case of an 87-year-old woman who was treated with oral corticosteroids for polymyalgia rheumatica for many years and developed erythema nodosum-like lesions on the right forearm and arthritis of the right wrist. By increasing the steroid dosage and adding methotrexate only short-term remission was achieved. Seven months later painful erythematous nodules occurred on all extremities which became necrotic, ulcerative and suppurative. Ziehl-Neelsen staining revealed acid-fast bacilli and Mycobacterium marinum was cultured from skin biopsies, blood, and urine. The critically ill patient was treated with clarithromycin and ethambutol resulting in a dramatic improvement of the general condition. After four months, doxycycline had to be added because of new skin lesions. This case illustrates the impact of Mycobacterium marinum infection in immunocompromised patients.


Asunto(s)
Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Mycobacterium marinum/aislamiento & purificación , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Antituberculosos/uso terapéutico , Bacteriemia/fisiopatología , Enfermedad Crítica , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Huésped Inmunocomprometido , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Infecciones por Mycobacterium no Tuberculosas/inmunología , Polimialgia Reumática/diagnóstico , Polimialgia Reumática/tratamiento farmacológico , Polimialgia Reumática/inmunología , Medición de Riesgo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA